Internal Medicine

3151 soru

Tüm türler3,151 Çoktan seçmeli1,611 Çoklu seçim73 Sayısal81 Eşleştirme714 Sıralama672

A 72-year-old male with a history of metastatic prostate cancer is admitted directly to the inpatient medical ward from his oncologist's clinic due to rapidly progressive lower extremity weakness. He reports a two-week history of worsening thoracic back pain that frequently awakens him from sleep. Over the last 24 hours, he has become entirely unable to stand or walk. He also mentions an inability to urinate since early this morning. Vital signs are within normal limits. Neurologic examination shows symmetric 2/5 motor strength in the lower extremities, diminished pinprick sensation below the T10 dermatome, and bilateral Babinski signs. A distended, palpable bladder is noted on abdominal examination. Complete blood count and basic metabolic panel, including serum calcium, are unremarkable.

Which of the following is the most appropriate initial step in the management of this patient?

Magnetic resonance imaging of the entire spine

Neurosurgical consultation for decompressive laminectomy

Administration of intravenous dexamethasone

Initiation of localized external beam radiation therapy

Infusion of intravenous zoledronic acid

Cevabı ve açıklamayı göster

Cevap: Administration of intravenous dexamethasone

Cevap

The most appropriate initial step is the administration of intravenous dexamethasone.

The patient's presentation of progressive back pain, bilateral lower extremity weakness, sensory level deficits, upper motor neuron signs (Babinski), and autonomic dysfunction (urinary retention) in the setting of metastatic prostate cancer is highly suspicious for neoplastic epidural spinal cord compression (ESCC). ESCC is a critical neurologic emergency. The immediate priority is to reduce vasogenic edema and relieve pressure on the spinal cord to prevent irreversible ischemia and permanent paralysis. Therefore, the administration of high-dose intravenous corticosteroids (such as dexamethasone) is the most appropriate initial step. It must be given as soon as the diagnosis is suspected clinically, prior to any confirmatory imaging.

Adım Adım Çözüm

Evaluate the patient's clinical signs and oncologic history.

Identify severe back pain, acute motor weakness, a sensory level deficit, and autonomic dysfunction (urinary retention) in a patient with known metastatic prostate cancer.

To recognize the classic presentation of neoplastic epidural spinal cord compression (ESCC), a major oncologic emergency.

Formulate a management priority based on the presence of acute neurologic deficits.

Determine that the immediate priority is to relieve pressure on the spinal cord to prevent permanent ischemia and irreversible paralysis.

In ESCC, 'time is spine'; any delay in relieving vasogenic edema can result in permanent loss of neurologic function.

Select the most appropriate initial intervention.

Choose the administration of high-dose intravenous corticosteroids (e.g., dexamethasone).

Corticosteroids act rapidly to decrease spinal cord edema and must be given immediately upon clinical suspicion, even prior to obtaining confirmatory imaging.

Anahtar Kavram

Management sequence for neoplastic epidural spinal cord compression

Soru 1242Soru →

Match each clinical vignette describing an adverse reaction to a packed red blood cell (pRBC) transfusion with the most appropriate next step in management.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Cevabı ve açıklamayı göster

Cevap

Acute hemolytic reaction matches with aggressive IV hydration; Febrile non-hemolytic reaction matches with administering an antipyretic; TRALI matches with supportive respiratory care; Allergic reaction matches with pausing, giving antihistamines, and resuming; and TACO matches with administering intravenous furosemide.

Each transfusion reaction has a distinct pathophysiologic mechanism that dictates its classic clinical presentation and subsequent management. Immediate life-threatening events like ABO incompatibility (Acute Hemolytic) require fluids to save the kidneys. Inflammatory but benign events (Febrile Non-Hemolytic) require simple antipyretics. Immune-mediated lung injury (TRALI) requires strict supportive respiratory care, while hydrostatic lung injury (TACO) requires aggressive diuresis. Finally, mild IgE-mediated reactions (Allergic) uniquely allow for pausing, treating the symptoms, and finishing the transfusion.

Adım Adım Çözüm

Identify the cause of flank pain and dark urine shortly after starting a transfusion.

Matches aggressive IV hydration.

Diagnosis is an acute hemolytic reaction; fluids are essential to prevent pigment nephropathy and renal failure.

Evaluate isolated fever and chills without hemodynamic instability.

Matches antipyretic administration.

Diagnosis is a febrile non-hemolytic reaction, requiring only symptom control after ruling out hemolysis.

Distinguish the cause of respiratory distress with pulmonary infiltrates but normal blood pressure.

Matches supportive respiratory care.

Diagnosis is TRALI; immune-mediated capillary permeability requires respiratory support, not diuresis.

Identify the significance of isolated urticaria and pruritus without systemic signs.

Matches administering antihistamines and resuming.

Diagnosis is a mild allergic reaction; the blood product can safely be utilized after symptom resolution.

Evaluate respiratory distress accompanied by hypertension and basilar crackles in an elderly patient.

Matches intravenous furosemide.

Diagnosis is TACO; the acute volume overload must be reversed with rapid diuresis.

Anahtar Kavram

Management and identification of acute blood transfusion reactions

Soru 1243Soru →

A 26-year-old woman presents to the clinic for sexually transmitted infection screening. She reports having condomless sexual intercourse with a new male partner three weeks ago. She recently learned that this partner is living with HIV and is not taking any medications. She currently feels well and has no symptoms of acute illness. Vital signs and physical examination are unremarkable. The physician decides to evaluate her for HIV. Assuming her initial screening test is reactive, but her subsequent confirmatory antibody test is indeterminate, arrange the following diagnostic and management steps in the correct chronological sequence according to the standard Centers for Disease Control and Prevention (CDC) HIV algorithm.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct sequence begins with the HIV-1/2 antigen/antibody combination immunoassay, followed by the HIV-1/HIV-2 antibody differentiation immunoassay. Due to the indeterminate result, an HIV-1 nucleic acid test (NAT) is performed next. Finally, antiretroviral therapy (ART) is initiated and baseline labs are drawn.

The correct sequence precisely follows the CDC diagnostic algorithm for HIV. The first step is the highly sensitive fourth-generation antigen/antibody combination test. If reactive, the second step is the differentiation assay to determine if the patient has HIV-1 or HIV-2 antibodies. Because this patient is in the acute phase of infection (only 3 weeks post-exposure), she has p24 antigenemia but has not yet developed a mature antibody response, resulting in a reactive step 1 but an indeterminate step 2. This specific discrepancy mandates step 3, an HIV-1 nucleic acid test (NAT), to detect viral RNA and confirm acute HIV-1 infection. Once the diagnosis is definitively confirmed by a positive NAT, step 4 is to initiate antiretroviral therapy (ART) and obtain baseline immunologic and virologic studies such as a CD4 count.

Adım Adım Çözüm

Perform the HIV-1/2 antigen/antibody combination immunoassay.

The test returns a reactive result.

This fourth-generation test is the highly sensitive initial screening tool mandated by the CDC algorithm, detecting both p24 antigen and antibodies.

Perform the HIV-1/HIV-2 antibody differentiation immunoassay.

The test returns an indeterminate result.

All reactive initial screens must be followed by this test to confirm infection and differentiate the viral type. The indeterminate result occurs because the patient is in the acute window phase (p24 antigen is present, but mature antibodies have not yet formed).

Perform an HIV-1 nucleic acid test (NAT).

The NAT returns a positive result for HIV-1 RNA.

NAT is required to resolve the discrepancy between the reactive combination test and the indeterminate differentiation test, confirming the diagnosis of acute HIV-1 infection.

Initiate antiretroviral therapy (ART) and obtain a baseline CD4 cell count.

The patient is started on a modern ART regimen.

Once the diagnosis is definitively confirmed via NAT, prompt initiation of ART is standard of care to suppress viral replication, preserve immune function, and prevent transmission.

Anahtar Kavram

Standard CDC HIV Diagnostic Algorithm and Identification of Acute HIV Infection

Soru 1244Soru →

Paramedics bring a lethargic $68$ -year-old male to the emergency department after his family found him confused and severely weak at home. The patient has a medical history of hypertension, hyperlipidemia, and type 2 diabetes mellitus. Vital signs upon arrival reveal a temperature of $34.8^\circ$ C ( $94.6^\circ$ F), blood pressure of $80/50$ mmHg, heart rate of $46$ /min, and respiratory rate of $8$ /min. On physical examination, the patient is somnolent but arousable to painful stimuli. His skin is cool, dry, and pale. There is non-pitting edema of the bilateral lower extremities, and deep tendon reflexes exhibit delayed relaxation phases. Lungs are clear to auscultation bilaterally, and cardiac examination reveals profound bradycardia with a regular rhythm. Initial laboratory studies show the following:

Serum sodium: $128$ mEq/L
Serum potassium: $4.0$ mEq/L
Serum chloride: $94$ mEq/L
Serum bicarbonate: $26$ mEq/L
Blood urea nitrogen: $18$ mg/dL
Serum creatinine: $1.1$ mg/dL
Serum glucose: $58$ mg/dL

Thyroid-stimulating hormone (TSH): $1.1$ $\mu$ U/mL (normal: $0.4-4.0$ $\mu$ U/mL)
Free thyroxine (T4): $0.3$ ng/dL (normal: $0.9-1.7$ ng/dL)

Arterial blood gas on room air:
pH: $7.22$
PaCO2: $65$ mm Hg
PaO2: $60$ mm Hg

Which of the following is the most appropriate initial step in the management of this patient?

Administer intravenous hydrocortisone followed by intravenous levothyroxine

Administer intravenous levothyroxine and initiate passive rewarming

Initiate noninvasive positive pressure ventilation and administer nebulized ipratropium-albuterol

Obtain blood cultures and administer empirical intravenous vancomycin and cefepime

Administer a continuous infusion of sodium bicarbonate

Cevabı ve açıklamayı göster

Cevap: Administer intravenous hydrocortisone followed by intravenous levothyroxine

Cevap

The most appropriate initial step is to administer intravenous hydrocortisone followed by intravenous levothyroxine.

The patient presents with classic signs of myxedema coma (hypothermia, bradycardia, altered mental status, and delayed reflexes). The laboratory finding of a very low free T4 combined with an inappropriately normal TSH points to central (secondary) hypothyroidism. In such cases, there is a high likelihood of concurrent panhypopituitarism, including central adrenal insufficiency (further supported by the patient's hypoglycemia). The standard of care mandates that intravenous glucocorticoids (e.g., hydrocortisone) be given prior to or simultaneously with intravenous levothyroxine. Administering thyroid hormone alone acutely increases the basal metabolic rate and accelerates the hepatic clearance of cortisol, which can precipitate a fatal Addisonian crisis in a cortisol-deficient patient.

Adım Adım Çözüm

Analyze the clinical presentation and vital signs.

The patient exhibits severe hypothermia, bradycardia, hypoventilation, hypotension, and delayed deep tendon reflexes.

These findings are hallmark signs of a profound hypometabolic state, specifically myxedema coma.

Interpret the endocrine laboratory results.

The free T4 is markedly low (

0.3

ng/dL) while the TSH is inappropriately normal (

1.1

\mu

U/mL).

This discrepancy indicates secondary (central) hypothyroidism rather than primary hypothyroidism. The accompanying hypoglycemia further suggests panhypopituitarism with central adrenal insufficiency.

Determine the correct pharmacological sequence for management.

Intravenous glucocorticoids (hydrocortisone) must be administered prior to intravenous thyroid hormone replacement.

Levothyroxine rapidly increases the basal metabolic rate and hepatic clearance of cortisol. In a patient with unrecognized adrenal insufficiency, this will precipitate a fatal acute adrenal crisis.

Anahtar Kavram

In myxedema coma, especially with laboratory evidence pointing toward central hypothyroidism (low free T4, inappropriately normal TSH), empiric intravenous glucocorticoids must be administered before levothyroxine to prevent precipitating an acute adrenal crisis.

Tahmini Süre:1m 30s

Soru 1245Soru →

Match each patient's clinical and microbiological presentation with the most appropriate targeted antimicrobial therapy.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Cevabı ve açıklamayı göster

Cevap

Listeria monocytogenes pairs with ampicillin; ESBL-producing E. coli pairs with meropenem; invasive aspergillosis pairs with voriconazole; and MRSA pairs with vancomycin.

Each pathogen has a distinct, well-established first-line treatment. Ampicillin is uniquely active against Listeria. Carbapenems (meropenem) are stable against extended-spectrum beta-lactamases produced by resistant Gram-negative rods. Voriconazole is the antifungal of choice for invasive Aspergillus. Vancomycin provides reliable coverage for oxacillin-resistant staphylococci (MRSA).

Adım Adım Çözüm

Identify the underlying pathogen described in each clinical vignette using key microbiological and serological terms.

Pathogens identified are Listeria monocytogenes, ESBL E. coli, Aspergillus species, and MRSA.

Accurate pathogen identification is required to select narrow, targeted antimicrobial therapy.

Determine the first-line targeted therapy for each identified organism.

Ampicillin for Listeria, meropenem for ESBL, voriconazole for Aspergillus, and vancomycin for MRSA.

Applying standard pharmacotherapy guidelines ensures effective treatment while adhering to antimicrobial stewardship principles.

Anahtar Kavram

Targeted Antimicrobial Therapy for Classic Pathogens

Tahmini Süre:1m 0s

Soru 1246Soru →

An oncology team is evaluating a 47-year-old male inpatient who has had persistent fever despite ongoing antimicrobial therapy. He has been hospitalized for the past $16$ days receiving induction chemotherapy for acute myeloid leukemia. Six days prior to the current evaluation, his absolute neutrophil count dropped to $90/\text{mm}^3$ , coinciding with a new-onset fever of $39.2^\circ\text{C}$ ( $102.6^\circ\text{F}$ ). At that time, comprehensive pan-culturing was performed, and empiric intravenous piperacillin-tazobactam was initiated.

Currently, the patient's temperature is $38.9^\circ\text{C}$ ( $102.0^\circ\text{F}$ ), blood pressure is $122/78 \text{ mmHg}$ , and pulse is $95/\text{min}$ . He reports feeling exhausted but has no focal symptoms such as cough, dyspnea, sinus pain, or dysuria. Physical examination reveals a clean, non-tender central venous catheter insertion site. Cardiopulmonary and abdominal examinations are unremarkable. The absolute neutrophil count remains profoundly low at $40/\text{mm}^3$ . All previous blood and urine cultures have remained sterile after six days of incubation. High-resolution computed tomography of the chest demonstrates no pulmonary nodules or infiltrates.

Which of the following is the most appropriate next step in pharmacotherapy?

Add intravenous caspofungin

Add intravenous vancomycin

Switch piperacillin-tazobactam to meropenem

Discontinue piperacillin-tazobactam and start intravenous liposomal amphotericin B

Continue the current regimen and observe closely

Cevabı ve açıklamayı göster

Cevap: Add intravenous caspofungin

Cevap

The most appropriate next step is to add an empiric antifungal agent, such as intravenous caspofungin.

Adding intravenous caspofungin is the correct next step. The patient has persistent neutropenic fever, defined as a fever lasting longer than 4 to 7 days despite receiving appropriate initial empiric broad-spectrum antibacterial therapy (in this case, piperacillin-tazobactam). In high-risk patients (such as those with profound neutropenia from induction chemotherapy), persistent fever often indicates an occult invasive fungal infection, most frequently involving Candida or Aspergillus species. Standard of care requires the addition of empiric antifungal therapy with an echinocandin (like caspofungin), a mold-active azole, or liposomal amphotericin B while continuing the antibacterial regimen until the neutrophil count recovers.

Adım Adım Çözüm

Identify the patient's primary clinical syndrome.

The patient has high-risk, prolonged neutropenic fever (ANC

< 500/\text{mm}^3

) that has persisted for 6 days despite appropriate initial empiric antibacterial therapy.

Recognizing the timeline and the unresponsiveness to piperacillin-tazobactam is critical for determining the next phase of the management algorithm.

Assess the risk of secondary or occult infections.

Patients with profound and prolonged neutropenia are at an exceptionally high risk for invasive fungal infections, most commonly caused by Candida and Aspergillus species.

Fungal pathogens are a common cause of culture-negative persistent fever in hematologic malignancy patients undergoing induction chemotherapy.

Apply the standard treatment protocol for persistent neutropenic fever.

Guidelines dictate that if a high-risk neutropenic patient remains febrile after 4 to 7 days of broad-spectrum antibacterial therapy and has no identified source, an empiric antifungal agent must be added.

Early initiation of antifungal therapy reduces mortality from occult invasive fungal infections in this vulnerable population.

Select the appropriate pharmacotherapy to add.

Adding intravenous caspofungin (an echinocandin) provides excellent empiric coverage for the suspected fungal organisms.

Echinocandins, liposomal amphotericin B, or mold-active azoles are the drugs of choice in this scenario.

Anahtar Kavram

In high-risk patients with neutropenic fever that persists for 4 to 7 days despite appropriate broad-spectrum antibacterial therapy, empiric antifungal coverage (e.g., caspofungin) should be added to prevent severe morbidity and mortality from invasive fungal infections.

Tahmini Süre:1m 30s

Soru 1247Soru →

Match each patient's clinical presentation and peripheral blood smear findings to the most likely underlying pathophysiologic mechanism.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Cevabı ve açıklamayı göster

Cevap

The correct matches align classic hematologic presentations with their distinct pathophysiologies: TTP is due to ADAMTS13 deficiency, ITP is due to anti-platelet antibodies, Warm AIHA is due to anti-RBC antibodies, and G6PD deficiency limits protection against oxidative stress.

Each patient's clinical scenario and lab findings perfectly align with a specific hematologic mechanism. The TTP case matches ADAMTS13 deficiency; the ITP case matches anti-platelet antibodies; the AIHA case matches anti-RBC antibodies; and the drug-induced bite cell hemolysis matches G6PD deficiency.

Adım Adım Çözüm

Analyze the first presentation: fever, confusion, microangiopathic hemolytic anemia (schistocytes), and thrombocytopenia with normal coagulation studies.

Identifies Thrombotic Thrombocytopenic Purpura (TTP).

TTP classically presents with this pentad (or partial pentad) and is driven by ADAMTS13 deficiency.

Analyze the second presentation: isolated thrombocytopenia with large platelets and normal coagulation studies in an otherwise healthy young woman.

Identifies Immune Thrombocytopenia (ITP).

ITP is an autoimmune condition caused by anti-GpIIb/IIIa IgG antibodies.

Analyze the third presentation: hemolytic anemia with spherocytes and a positive direct antiglobulin test (DAT) in a patient with CLL.

Identifies Warm Autoimmune Hemolytic Anemia (AIHA).

Warm AIHA is mediated by IgG antibodies against RBC antigens and is frequently associated with CLL.

Analyze the fourth presentation: acute hemolytic anemia with bite cells following exposure to an oxidative stressor (sulfamethoxazole-trimethoprim).

Identifies Glucose-6-Phosphate Dehydrogenase (G6PD) deficiency.

G6PD deficiency impairs the RBC's ability to produce NADPH, leading to oxidative damage when exposed to sulfa drugs.

Anahtar Kavram

The diagnosis of hematologic disorders requires integrating clinical findings, specific peripheral blood smear abnormalities, and an understanding of the underlying autoimmune or enzymatic pathophysiology.

Tahmini Süre:2m 0s

Soru 1248Soru →

A 28-year-old male graduate student presents to the university health center reporting a 3-day history of profound fatigue, a severe sore throat, and a widespread rash. He notes that 14 days ago, he engaged in unprotected receptive anal intercourse with a new male partner whose infectious status is unknown. His temperature is $38.4^\circ\text{C}$ ( $101.1^\circ\text{F}$ ). Physical examination reveals tender cervical and axillary lymphadenopathy, pharyngeal erythema without exudate, and a diffuse maculopapular rash on the trunk and extremities. The physician suspects an acute viral illness and initiates the standard diagnostic algorithm for the most likely pathogen.

Arrange the following steps in the most appropriate chronological sequence for the diagnosis and initial management of this patient.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct sequence is: 1) HIV-1/2 antigen/antibody combination immunoassay, 2) HIV-1/HIV-2 antibody differentiation immunoassay, 3) HIV-1 NAAT, 4) Obtain baseline genotypic resistance testing, and 5) Initiate empiric antiretroviral therapy.

The standard of care for suspected acute HIV follows a strict chronological pathway. Diagnosis begins with the 4th-generation Ag/Ab immunoassay. If positive, it is followed by an antibody differentiation assay. In acute infection, the differentiation assay is negative or indeterminate because antibodies have not yet formed, which mandates an HIV-1 NAAT to confirm the diagnosis. Once confirmed, blood for genotypic resistance testing must be drawn prior to starting treatment. Finally, empiric antiretroviral therapy is initiated rapidly without waiting for the resistance results to return.

Adım Adım Çözüm

Recognize the clinical presentation of acute HIV infection (acute retroviral syndrome).

The patient's timeline (14 days post-high-risk exposure) and symptoms (fever, pharyngitis, lymphadenopathy, maculopapular rash) are highly suspicious for acute HIV.

Identifying acute HIV dictates the need for a specific diagnostic algorithm, as traditional antibody-only tests will be falsely negative during this window period.

Sequence the CDC diagnostic testing algorithm for HIV.

The initial step is the 4th-generation Ag/Ab immunoassay, followed by the antibody differentiation assay, and concluding with the HIV-1 NAAT.

The 4th-generation test detects the p24 antigen early. The reflex differentiation assay will be negative/indeterminate because antibodies haven't formed yet. The NAAT resolves this by directly detecting viral RNA, confirming acute infection.

Determine the optimal sequence for initiating treatment.

Genotypic resistance testing is drawn first, followed immediately by the rapid initiation of empiric antiretroviral therapy (ART).

ART suppresses viral replication, so resistance testing must be drawn beforehand to ensure accurate baseline data. However, ART initiation should not be delayed while waiting days to weeks for these results.

Anahtar Kavram

The diagnosis of acute HIV requires a sequential algorithm: a 4th-generation Ag/Ab combination immunoassay, followed by an antibody differentiation assay (often negative in early infection), and finally an HIV-1 NAAT for confirmation. Management requires drawing genotypic resistance labs prior to the rapid initiation of empiric antiretroviral therapy.

Soru 1249Soru →

An infectious diseases consultation is requested for a 74-year-old woman admitted with subacute bacterial endocarditis. She has a history of osteoarthritis and underwent a screening colonoscopy with polypectomy one month ago. She presented to the hospital with three weeks of low-grade fever, severe fatigue, and a new holosystolic murmur heard loudest at the cardiac apex. Transesophageal echocardiography revealed a $14\text{ mm}$ , highly mobile vegetation on the anterior mitral valve leaflet.

Four sets of blood cultures drawn upon admission are positive for *Enterococcus faecalis*. The microbiology laboratory provides the following antimicrobial susceptibility report:

Antimicrobial	Susceptibility Result
Ampicillin	Susceptible
Ceftriaxone	Resistant
Gentamicin (high-level screen)	Resistant
Linezolid	Susceptible
Vancomycin	Susceptible

Based on the susceptibility profile provided, which of the following is the most appropriate targeted pharmacotherapy to achieve bactericidal activity in this patient?

Intravenous ampicillin and intravenous ceftriaxone

Intravenous ampicillin and intravenous gentamicin

Intravenous ampicillin monotherapy

Intravenous vancomycin and intravenous piperacillin-tazobactam

Intravenous daptomycin monotherapy

Cevabı ve açıklamayı göster

Cevap: Intravenous ampicillin and intravenous ceftriaxone

Cevap

Intravenous ampicillin and intravenous ceftriaxone

The correct targeted therapy is intravenous ampicillin and intravenous ceftriaxone. Enterococcal infective endocarditis requires a bactericidal regimen, which historically consisted of ampicillin plus an aminoglycoside (e.g., gentamicin) to achieve synergy. However, this patient's isolate demonstrates high-level aminoglycoside resistance (HLAR), meaning gentamicin cannot penetrate the cell wall and will not provide synergy. The standard of care for HLAR Enterococcus faecalis endocarditis is dual beta-lactam therapy with ampicillin and ceftriaxone. Even though enterococci are intrinsically resistant to cephalosporins in vitro, ceftriaxone saturates penicillin-binding proteins (PBP) 2 and 3, allowing ampicillin to more effectively bind its targets (PBP 4 and 5). This mechanism results in profound synergistic bactericidal activity, effectively curing the endocarditis while avoiding aminoglycoside-induced nephrotoxicity.

Adım Adım Çözüm

Analyze the clinical presentation and primary diagnosis.

The patient has native valve infective endocarditis caused by Enterococcus faecalis.

Establishing the specific pathogen and site of infection dictates the necessity for a prolonged, bactericidal antimicrobial regimen.

Evaluate the microbiology susceptibility report.

The isolate is susceptible to ampicillin but shows high-level resistance to gentamicin (HLAR).

Enterococci are intrinsically tolerant to many antibiotics; bactericidal activity usually requires synergy between a cell-wall active agent (like ampicillin) and an aminoglycoside. HLAR eliminates the option of using gentamicin for synergy.

Determine the alternative synergistic regimen for HLAR Enterococcus faecalis.

Ampicillin combined with ceftriaxone is selected as the optimal regimen.

Despite enterococci being intrinsically resistant to cephalosporins (as shown on the report), ceftriaxone synergizes with ampicillin by saturating complementary penicillin-binding proteins (PBPs), achieving the necessary bactericidal effect without nephrotoxicity.

Anahtar Kavram

Management of Enterococcus faecalis infective endocarditis with High-Level Aminoglycoside Resistance (HLAR) using dual beta-lactam synergy (Ampicillin + Ceftriaxone).

Tahmini Süre:1m 30s

Soru 1250Soru →

A $74$ -year-old woman is brought to the emergency department by her daughter due to a recent episode of vision loss in her right eye. The patient states that while eating breakfast this morning, a "dark curtain" descended over her right eye, causing complete blindness in that eye for approximately $15$ minutes before fully resolving. Over the past $3$ weeks, she has experienced a persistent right-sided headache, generalized fatigue, and pain in her jaw muscles that worsens when she chews. Her medical history is significant for hypertension and polymyalgia rheumatica. Her temperature is $37.8^\circ\text{C}$ ( $100.0^\circ\text{F}$ ), blood pressure is $135/85\text{ mmHg}$ , and pulse is $88/\text{min}$ . Physical examination shows a prominent, nodular, and tender right temporal artery with diminished pulsation. Visual acuity is currently $20/20$ in both eyes. Laboratory studies show:

Hemoglobin: $11.2\text{ g/dL}$
Leukocyte count: $9,500/\text{mm}^3$
Erythrocyte sedimentation rate: $95\text{ mm/h}$
C-reactive protein: $45\text{ mg/L}$

Which of the following is the most appropriate next step in management?

Obtain a non-contrast computed tomography of the head

Initiate high-dose oral prednisone

Administer intravenous methylprednisolone

Perform a temporal artery biopsy

Administer intravenous ceftriaxone and vancomycin

Cevabı ve açıklamayı göster

Cevap: Administer intravenous methylprednisolone

Cevap

Administer intravenous methylprednisolone

This patient's presentation is classic for giant cell arteritis (GCA), characterized by a new-onset headache, jaw claudication, an abnormal temporal artery on palpation, and a markedly elevated erythrocyte sedimentation rate (ESR). Her history of polymyalgia rheumatica further increases the pretest probability of GCA. The critical feature in this vignette is the episode of transient monocular vision loss (amaurosis fugax). In GCA, visual symptoms indicate active retinal ischemia due to arteritic anterior ischemic optic neuropathy. To prevent permanent, irreversible blindness, patients with suspected GCA and visual symptoms must receive immediate pulse intravenous methylprednisolone (typically

500

1000\text{ mg}

daily for

3

days). Once therapy is initiated, a temporal artery biopsy should be scheduled to confirm the diagnosis, as biopsy results remain reliable for

1

2

weeks after starting glucocorticoids.

Adım Adım Çözüm

Identify the primary clinical syndrome.

The patient has a new-onset headache, jaw claudication, temporal artery tenderness, and a highly elevated erythrocyte sedimentation rate in the setting of polymyalgia rheumatica, which is highly suggestive of giant cell arteritis (GCA).

Recognizing the classic triad of symptoms and laboratory findings establishes the working diagnosis.

Assess for severe or organ-threatening complications.

The patient experienced a transient loss of vision (amaurosis fugax) in the right eye.

Amaurosis fugax in the setting of GCA indicates active retinal ischemia and represents an impending permanent vision loss, which significantly alters the standard treatment pathway.

Determine the most appropriate initial management based on the presence of complications.

Intravenous pulse methylprednisolone must be administered immediately.

While uncomplicated GCA is treated with oral prednisone, the presence of ischemic visual symptoms mandates aggressive intravenous glucocorticoid therapy to prevent irreversible blindness. A temporal artery biopsy should be planned but must not delay treatment.

Anahtar Kavram

Management of giant cell arteritis (GCA) with visual symptoms

Tahmini Süre:1m 30s

Soru 1251Soru →

A 68-year-old woman is admitted to the hospital with profound fatigue, exertional dyspnea, and tingling in her toes. Laboratory studies reveal a hemoglobin of $5.8\text{ g/dL}$ , a mean corpuscular volume (MCV) of $122\text{ fL}$ , and a platelet count of $105,000/\mu\text{L}$ . A peripheral blood smear demonstrates macro-ovalocytes and neutrophils with six to seven nuclear lobes. The patient is diagnosed with severe cobalamin (vitamin $B_{12}$ ) deficiency secondary to pernicious anemia, and daily intramuscular cyanocobalamin therapy is initiated.

Arrange the following anticipated clinical and hematologic responses in the correct chronological order of their occurrence, from earliest to latest.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct chronological sequence is: Intracellular shift of potassium (1-2 days) → Peak elevation of reticulocyte count (5-8 days) → Clearance of hypersegmented neutrophils (10-14 days) → Normalization of hemoglobin concentration (4-8 weeks) → Complete normalization of MCV (3-4 months).

The physiological response to cobalamin replacement follows a strict timeline dictated by cellular kinetics. Marrow conversion and the resulting intracellular potassium shift occur first (1-2 days). This allows for the production and release of reticulocytes, which peak shortly after (5-8 days). As normal hematopoiesis resumes, the preexisting hypersegmented neutrophils die off according to their short lifespan (10-14 days). Hemoglobin levels gradually build up over several weeks (4-8 weeks). Finally, because the large, abnormal red blood cells produced before treatment survive for 120 days, the MCV takes the longest to normalize (3-4 months).

Adım Adım Çözüm

Identify the earliest metabolic change resulting from bone marrow conversion.

Intracellular shift of potassium leading to potential hypokalemia.

Initiation of cyanocobalamin triggers immediate proliferation of hematopoietic precursors. This rapid cell division requires massive cellular uptake of potassium, occurring within the first 24-48 hours.

Identify the earliest peripheral blood evidence of new red blood cell production.

Peak elevation of the peripheral blood reticulocyte count.

As new erythrocytes are manufactured, reticulocytes enter the bloodstream. This count begins to rise by day 3 and peaks between days 5 and 8.

Determine the timeline for the disappearance of abnormal leukocyte morphology.

Clearance of hypersegmented neutrophils from the peripheral smear.

Circulating hypersegmented neutrophils must complete their natural lifespan (a few days) before they are entirely replaced by normal neutrophils, which typically takes 10 to 14 days.

Determine the timeline for the restoration of normal oxygen-carrying capacity.

Normalization of the hemoglobin concentration.

Hemoglobin rises steadily at a rate of approximately

1\text{ g/dL}

per week, requiring 4 to 8 weeks to reach the normal reference range.

Determine the timeline for the clearance of all previously formed abnormal red blood cells.

Complete normalization of the mean corpuscular volume (MCV).

Because red blood cells live for 120 days, the macrocytic cells produced prior to therapy remain in circulation for months. The MCV will not fully normalize until these older cells have all undergone senescence (up to 3-4 months).

Anahtar Kavram

Timeline of physiologic and hematologic responses to cobalamin replacement in severe megaloblastic anemia

Soru 1252Soru →

A 55-year-old man is evaluated in the hospital prior to discharge. Three days ago, he was admitted for a diabetic foot infection characterized by a 3-cm area of erythema, induration, and warmth surrounding a shallow, non-purulent ulcer on the plantar surface of his right foot. Upon admission, he was afebrile, and his vital signs were within normal limits. He was started on empiric intravenous vancomycin and piperacillin-tazobactam. Today, the erythema has decreased to 1 cm, and the patient is ambulating without difficulty. Deep tissue cultures obtained during initial debridement on admission have grown methicillin-susceptible Staphylococcus aureus (MSSA) and Streptococcus agalactiae. Susceptibility testing shows both isolates are sensitive to cefazolin, cephalexin, and amoxicillin-clavulanate. The patient is tolerating a regular diet. Which of the following is the most appropriate antibiotic regimen for this patient upon discharge?

Oral linezolid and oral amoxicillin-clavulanate

Oral moxifloxacin

Oral cephalexin

Intravenous cefepime

Intravenous vancomycin and oral ciprofloxacin

Cevabı ve açıklamayı göster

Cevap: Oral cephalexin

Cevap

Oral cephalexin

Oral cephalexin is the most appropriate next step because it provides targeted, narrow-spectrum coverage against the specific identified organisms (MSSA and Streptococcus agalactiae). The patient is clinically stable, recovering well, and tolerating a regular diet, which safely allows for the discontinuation of broad-spectrum intravenous therapy (vancomycin and piperacillin-tazobactam) in favor of a highly bioavailable, targeted oral agent.

Adım Adım Çözüm

Identify the patient's clinical status and trajectory.

The patient is clinically improving, hemodynamically stable, and tolerating oral intake.

This establishes that the patient is a safe candidate for transition from intravenous to oral antibiotic therapy.

Analyze the deep tissue culture and susceptibility data.

Cultures grew methicillin-susceptible Staphylococcus aureus (MSSA) and Streptococcus agalactiae, both of which are sensitive to first-generation cephalosporins.

Definitive culture data from deep tissue is the gold standard for guiding targeted therapy in diabetic foot infections.

Apply principles of antibiotic stewardship.

Select oral cephalexin to complete the treatment course.

De-escalating from broad-spectrum empiric therapy to the narrowest-spectrum, effective oral agent minimizes adverse effects, reduces healthcare costs, and prevents the emergence of antimicrobial resistance.

Anahtar Kavram

De-escalation of empiric broad-spectrum antibiotics to targeted, narrow-spectrum oral therapy based on clinical improvement and definitive culture susceptibilities.

Soru 1253Soru →

Match each clinical vignette describing a patient with a hypercoagulable or thrombotic disorder to the underlying pathophysiologic mechanism responsible for their presentation.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Cevabı ve açıklamayı göster

Cevap

Factor V Leiden matches to the inherited mutation resisting natural anticoagulants; Antiphospholipid syndrome matches to autoantibodies affecting phospholipid assays; Polycythemia vera matches to the acquired JAK2 mutation; Warfarin-induced skin necrosis matches to the rapid depletion of a short half-life protein.

Each clinical scenario uniquely maps to a distinct mechanism of hypercoagulability. The presentation of APC resistance is exclusive to Factor V Leiden. The inhibitor pattern on mixing study that corrects with phospholipids is the defining laboratory feature of Lupus Anticoagulant. Pancytosis with low EPO and an atypical venous thrombosis points unequivocally to the JAK2 mutation in Polycythemia Vera. Finally, skin necrosis upon warfarin initiation is the classic presentation of a rapid, drug-induced decline in Protein C.

Adım Adım Çözüm

Analyze the first vignette describing activated protein C (APC) resistance.

Identify Factor V Leiden, a condition caused by a missense mutation in Factor V that prevents its normal cleavage and degradation by APC.

Connecting the diagnostic laboratory finding (APC resistance) to its fundamental genetic etiology.

Analyze the second vignette describing recurrent miscarriages and a specific coagulation mixing study profile.

Identify Lupus Anticoagulant (Antiphospholipid Syndrome), where autoantibodies prolong aPTT in vitro (inhibitor pattern) but correct with excess phospholipids.

Distinguishing between factor deficiencies and specific autoimmune inhibitors using standard mixing studies.

Analyze the third vignette detailing portal vein thrombosis, aquagenic pruritus, and pancytosis with low EPO.

Diagnose Polycythemia Vera, a myeloproliferative neoplasm caused by an acquired JAK2 tyrosine kinase mutation.

Recognizing the classic clinical presentation of PV and linking it to its molecular basis.

Analyze the fourth vignette describing necrotic skin lesions occurring shortly after starting a new oral anticoagulant.

Identify warfarin-induced skin necrosis, which occurs due to the rapid decline of Protein C before other procoagulant factors fall.

Linking the adverse drug reaction timeline to the pharmacokinetics of vitamin K-dependent factors.

Anahtar Kavram

Pathophysiology and diagnostic hallmarks of acquired and inherited hypercoagulable states (Factor V Leiden, Antiphospholipid Syndrome, Polycythemia Vera, and Protein C deficiency/Warfarin necrosis).

Tahmini Süre:2m 0s

Soru 1254Soru →

A 72-year-old man is evaluated on postoperative day 3 following an elective open inguinal hernia repair. He complains of sudden, severe pain and swelling in his right knee that woke him from sleep. His medical history is significant for chronic kidney disease with a baseline serum creatinine of 2.6 mg/dL, and hypertension. His current medications include subcutaneous enoxaparin and oral diltiazem. Temperature is 38.3°C (100.9°F), blood pressure is 142/84 mm Hg, and heart rate is 92/min. Physical examination shows a warm, markedly swollen, and erythematous right knee. Range of motion is severely limited by pain. Laboratory studies show a leukocyte count of 12,500/µL and a serum creatinine of 2.7 mg/dL. Arthrocentesis of the right knee yields 25 mL of turbid yellow fluid. Synovial fluid analysis reveals a leukocyte count of 35,000/µL (85% neutrophils). Polarized light microscopy demonstrates numerous rhomboid-shaped crystals with positive birefringence. Gram stain reveals no organisms. Which of the following is the most appropriate next step in the management of this patient?

Obtain a chest radiograph and blood cultures

Oral indomethacin

Intra-articular triamcinolone injection

Oral colchicine

Intravenous vancomycin and ceftriaxone

Cevabı ve açıklamayı göster

Cevap: Intra-articular triamcinolone injection

Cevap

Intra-articular triamcinolone injection

The most appropriate next step in management is an intra-articular glucocorticoid injection. This patient is experiencing an acute flare of calcium pyrophosphate deposition (CPPD) disease (pseudogout). This diagnosis is established by the acute monoarticular presentation and the synovial fluid analysis demonstrating an inflammatory effusion with rhomboid-shaped, positively birefringent crystals. First-line therapies for an acute pseudogout flare include NSAIDs, colchicine, and glucocorticoids (systemic or intra-articular). However, this patient's advanced chronic kidney disease (serum creatinine 2.7 mg/dL) strictly contraindicates the use of NSAIDs. Colchicine is also a poor choice due to its reliance on renal clearance and an extremely dangerous drug-drug interaction with diltiazem (a moderate CYP3A4 inhibitor). Concomitant use of colchicine and a CYP3A4 inhibitor in a patient with renal failure strongly risks fatal colchicine toxicity. For acute monoarthritis in a patient with multiple systemic comorbidities and contraindications, an intra-articular glucocorticoid injection (such as triamcinolone) provides targeted, highly effective relief with negligible systemic absorption or renal risk.

Adım Adım Çözüm

Diagnose the underlying acute joint pathology using synovial fluid analysis.

The presence of an inflammatory fluid (35,000 leukocytes/µL) with numerous rhomboid-shaped, positively birefringent crystals and a negative Gram stain confirms an acute flare of calcium pyrophosphate deposition (CPPD) disease (pseudogout).

Establishing the correct diagnosis prevents unnecessary empiric therapies, such as antibiotics for septic arthritis.

Evaluate standard first-line therapies for acute CPPD arthritis against the patient's comorbidities.

First-line therapies include NSAIDs, colchicine, and systemic or intra-articular glucocorticoids. The patient has stage 4 chronic kidney disease (CKD).

Renal function heavily dictates the safety profile of standard rheumatologic medications.

Eliminate contraindicated or highly risky pharmacologic options.

NSAIDs (e.g., indomethacin) are contraindicated in advanced CKD. Colchicine requires severe dose reduction in CKD and is further contraindicated here because the patient takes diltiazem, a CYP3A4 inhibitor that blocks colchicine metabolism, risking fatal toxicity.

Preventing severe iatrogenic harm, including acute-on-chronic renal failure and colchicine toxicity (neuromyopathy, myelosuppression).

Select the safest, most effective remaining intervention.

Intra-articular glucocorticoid injection (e.g., triamcinolone) is chosen.

It provides rapid, targeted anti-inflammatory effects for a single joint without significant systemic absorption, bypassing renal and metabolic contraindications.

Anahtar Kavram

For patients with an acute flare of calcium pyrophosphate deposition (CPPD) disease who have severe renal impairment or take interacting medications (e.g., CYP3A4 inhibitors), intra-articular glucocorticoids are the safest and most appropriate initial therapy.

Soru 1255Soru →

A 62-year-old man comes to the physician due to a 3-month history of progressively worsening fatigue, shortness of breath when climbing stairs, and a tingling sensation in both feet. He has a history of type 2 diabetes mellitus, hypertension, and osteoarthritis. His current medications include metformin, lisinopril, and acetaminophen. Vital signs are within normal limits. Physical examination demonstrates marked conjunctival pallor and decreased vibratory sensation in the lower extremities bilaterally. Lung fields are clear to auscultation. There is no jugular venous distention or lower extremity edema. Laboratory studies reveal:

Hemoglobin: 8.8 g/dL
Mean corpuscular volume (MCV): 114 fL
White blood cell count: 4,800/mm³
Platelet count: 140,000/mm³

A peripheral blood smear demonstrates macro-ovalocytes and several neutrophils with six or more nuclear lobes.

Which of the following is the most appropriate next step in the management of this patient?

Initiate intravenous furosemide therapy

Prescribe a course of oral levofloxacin

Order a serum vitamin B12 level

Measure thyroid-stimulating hormone and free T4 levels

Discontinue lisinopril and start a different antihypertensive agent

Cevabı ve açıklamayı göster

Cevap: Order a serum vitamin B12 level

Cevap

The most appropriate next step is to order a serum vitamin B12 level to confirm the diagnosis before initiating supplementation.

The correct answer involves ordering a serum vitamin B12 level. The patient presents with classic clinical and laboratory signs of megaloblastic anemia, which is characterized by a significantly elevated mean corpuscular volume (MCV > 110 fL) and the pathognomonic presence of hypersegmented neutrophils on a peripheral blood smear. Furthermore, the patient exhibits neurologic symptoms, specifically peripheral neuropathy with decreased vibratory sensation, which is a hallmark of vitamin B12 (cobalamin) deficiency and reliably distinguishes it from folate deficiency. The patient is also taking metformin, a medication well-known to interfere with calcium-dependent terminal ileum absorption of the intrinsic factor-vitamin B12 complex. Before initiating targeted replacement therapy, standard medical practice dictates confirming the diagnosis by measuring serum vitamin B12 levels.

Adım Adım Çözüm

Analyze the clinical presentation and laboratory results.

The patient has a macrocytic anemia (MCV = 114 fL) combined with neurologic symptoms (tingling, decreased vibratory sensation).

Identifying the type of anemia narrows down the differential diagnosis significantly.

Interpret the peripheral blood smear findings.

The presence of macro-ovalocytes and hypersegmented neutrophils (> 5 nuclear lobes) is identified.

These findings are highly specific for megaloblastic anemia, which is primarily caused by defective DNA synthesis.

Synthesize the findings with the patient's history.

Megaloblastic anemia with dorsal column neurologic signs strongly points to vitamin B12 deficiency. The patient's long-term use of metformin is a known pharmacological risk factor for this deficiency.

Connecting the pathophysiology to the patient's specific medication list establishes the most likely etiology.

Determine the most appropriate initial management step.

Ordering a serum vitamin B12 level is chosen as the next step.

Before initiating lifelong or long-term replacement therapy, the suspected deficiency must be formally confirmed via laboratory testing.

Anahtar Kavram

Recognition of megaloblastic anemia, its association with vitamin B12 deficiency (often secondary to long-term metformin use), and the appropriate initial diagnostic workup.

Alternatif Yöntem

If the initial serum vitamin B12 level returns in the low-normal or borderline range (typically 200-300 pg/mL), measuring serum methylmalonic acid (MMA) is the best alternative method to confirm tissue-level B12 deficiency, as MMA will be consistently elevated.

Tahmini Süre:1m 0s

Soru 1256Soru →

A $24$ -year-old man presents to the clinic with a $2$ -month history of painless swelling in the right side of his neck. He also reports drenching night sweats and an unintentional $5$ -kg ( $11$ -lb) weight loss over this period. Physical examination reveals a non-tender, firm, mobile $3$ -cm cervical lymph node. Arrange the following steps in the correct sequential order for the definitive diagnosis, staging, and management of this patient's most likely condition.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct sequence is to first secure a tissue diagnosis via excisional biopsy, followed by baseline PET/CT staging, then the initiation of targeted chemotherapy, and finally restaging with a follow-up PET/CT scan.

The fundamental algorithmic approach in oncology is 'Diagnose, Stage, Treat, Monitor'. For a young patient with B symptoms (night sweats, weight loss) and persistent lymphadenopathy highly suspicious for Hodgkin lymphoma, an excisional biopsy is mandatory to secure the diagnosis. Following this, a PET/CT is required for accurate baseline staging. Only then is stage-directed chemotherapy initiated, followed later by a repeat PET/CT scan to assess metabolic and anatomic treatment efficacy.

Adım Adım Çözüm

Establish a definitive tissue diagnosis.

Perform an excisional lymph node biopsy.

Fine-needle aspiration is often insufficient for diagnosing lymphoma. An excisional biopsy preserves the nodal architecture required for accurate histologic classification.

Determine the anatomic and metabolic extent of the disease.

Obtain an FDG PET/CT scan.

Accurate baseline staging (e.g., Ann Arbor system) is essential because it determines the intensity, number of cycles, and specific type of treatment required.

Administer definitive systemic treatment.

Initiate multiagent chemotherapy.

Once the specific diagnosis and stage are confirmed, the appropriately tailored chemotherapy regimen can be safely initiated.

Assess the therapeutic response.

Perform a follow-up PET/CT scan.

Interim or end-of-treatment restaging evaluates whether the disease is responding to the chemotherapy, allowing clinicians to modify therapy appropriately.

Anahtar Kavram

The standard oncologic paradigm for suspected lymphoma follows a strict sequence: obtain a definitive tissue diagnosis (excisional biopsy), perform baseline staging to determine disease extent (PET/CT), initiate stage-appropriate therapy, and subsequently monitor treatment response.

Tahmini Süre:45s

Soru 1257Soru →

A 48-year-old woman is brought to the emergency department by her husband due to a 24-hour history of severe generalized headache, high fever, and progressive confusion. She has a history of a deceased-donor renal transplant 3 years ago and takes tacrolimus, mycophenolate mofetil, and prednisone. Her temperature is 39.2°C (102.6°F), blood pressure is 112/68 mmHg, pulse is 115/min, and respirations are 18/min. On examination, the patient is lethargic but arousable to verbal stimuli. Marked nuchal rigidity is present. Neurologic examination reveals a new-onset right-sided pronator drift and a mild right lower facial droop. Arrange the following next steps in management in the most appropriate chronological order.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct chronological sequence is: 1) Obtain peripheral blood cultures, 2) Administer empiric dexamethasone and antimicrobials, 3) Obtain a CT scan of the head, and 4) Perform a lumbar puncture.

In patients with suspected bacterial meningitis, the primary goal is to obtain cerebrospinal fluid (CSF) for analysis and initiate targeted antibiotics as rapidly as possible. However, performing a lumbar puncture (LP) in the setting of increased intracranial pressure due to a mass lesion can lead to fatal brain herniation. Therefore, a head CT must be performed prior to LP in patients who meet specific high-risk criteria, which include: an immunocompromised state (e.g., solid organ transplant), altered level of consciousness, focal neurologic deficits (e.g., hemiparesis, facial droop), new-onset seizures, or papilledema. Because obtaining a head CT will delay the LP, empiric therapy must not be postponed. The optimal sequence is to immediately draw blood cultures to maximize diagnostic yield, rapidly administer empiric antibiotics alongside dexamethasone (to reduce meningeal inflammation), perform the head CT to rule out mass effect, and finally perform the LP if the CT shows it is safe to proceed.

Adım Adım Çözüm

Identify the suspected diagnosis and recognize red flag features.

The patient has symptoms of bacterial meningitis (fever, headache, nuchal rigidity, confusion) along with focal neurologic deficits (pronator drift, facial droop) and an immunocompromised state.

Recognizing red flags dictates whether a lumbar puncture can be performed immediately or if prior neuroimaging is required.

Determine the safety of an immediate lumbar puncture.

Lumbar puncture must be delayed until a head CT is performed.

Patients with altered mental status, focal neurologic deficits, or immunocompromise are at high risk for intracranial mass effect. An immediate LP could precipitate fatal brain herniation.

Sequence the diagnostic and therapeutic interventions to avoid delaying treatment.

Blood cultures are drawn first, followed immediately by empiric antibiotics and dexamethasone, then the CT scan, and finally the LP.

Because the CT scan delays the definitive diagnostic LP, empiric antibiotics must not be withheld. Blood cultures take minutes and should be drawn prior to antibiotics to optimize microbiological yield.

Anahtar Kavram

Management sequence for suspected bacterial meningitis with indications for head CT before lumbar puncture.

Tahmini Süre:1m 30s

Soru 1258Soru →

A 76-year-old man is hospitalized for symptomatic anemia. His past medical history is significant for severe chronic obstructive pulmonary disease (COPD), hypertension, and ischemic cardiomyopathy with a left ventricular ejection fraction of 35%. His hemoglobin is 6.4 g/dL. A transfusion of packed red blood cells is initiated. Two hours later, he develops acute shortness of breath and a cough producing frothy sputum.

Vital signs:
Temperature: 37.2°C (99.0°F)
Blood pressure: 170/95 mmHg
Pulse: 115/min
Respiratory rate: 26/min
Pulse oximetry: 88% on room air

Physical examination reveals markedly elevated jugular venous pressure. Lung auscultation demonstrates bilateral basilar crackles and diffuse expiratory wheezes. Cardiac auscultation reveals an S3 gallop and a regular tachycardia.

Which of the following is the most appropriate next step in management?

Discontinue the transfusion and administer inhaled albuterol

Pause the transfusion and administer oral acetaminophen

Discontinue the transfusion and administer intravenous furosemide

Discontinue the transfusion and administer intravenous normal saline

Discontinue the transfusion and administer intravenous piperacillin-tazobactam

Cevabı ve açıklamayı göster

Cevap: Discontinue the transfusion and administer intravenous furosemide

Cevap

Discontinue the transfusion and administer intravenous furosemide

The correct answer addresses the patient's Transfusion-Associated Circulatory Overload (TACO). TACO is characterized by acute respiratory distress, hypertension, tachycardia, elevated jugular venous pressure, and pulmonary edema (manifesting as crackles and an S3 gallop) occurring during or within 6 hours of a blood transfusion. Patients with underlying cardiopulmonary disease (such as this patient's ischemic cardiomyopathy) are at the highest risk due to an inability to handle the rapid expansion of intravascular volume. The most appropriate initial step is to immediately discontinue the transfusion and administer a diuretic, such as intravenous furosemide, along with supplemental oxygen and ventilatory support if necessary.

Adım Adım Çözüm

Analyze the patient's acute presentation during the blood transfusion.

The patient developed acute respiratory distress, hypertension, elevated jugular venous pressure, pulmonary crackles, wheezing, and an S3 gallop.

Identifying the specific clinical signs and vital sign derangements is essential to differentiate between the types of acute transfusion reactions.

Differentiate Transfusion-Associated Circulatory Overload (TACO) from other cardiopulmonary etiologies.

The combination of volume overload signs (elevated JVP, S3 gallop, severe hypertension) strongly points to TACO. This rules out Transfusion-Related Acute Lung Injury (TRALI), which typically presents with hypotension and no JVD, as well as a COPD exacerbation, which would lack the signs of acute heart failure.

Accurate diagnosis based on hemodynamics dictates the specific intervention required.

Determine the most appropriate next step in management.

The immediate required steps are to stop the transfusion, provide respiratory support (oxygen), and administer diuretics such as intravenous furosemide to reduce the excess intravascular volume.

Stopping the offending agent and addressing the profound volume overload are life-saving measures in TACO.

Anahtar Kavram

Transfusion-Associated Circulatory Overload (TACO) typically presents with acute respiratory distress, hypertension, tachycardia, and signs of cardiogenic pulmonary edema (elevated JVP, S3 gallop) during or shortly after a blood transfusion. Management involves stopping the transfusion, providing supplemental oxygen, and administering diuretics.

Soru 1259Soru →

Match each patient's clinical presentation with the most likely characteristic finding on muscle biopsy.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Cevabı ve açıklamayı göster

Cevap

The correct matches align Inclusion Body Myositis with rimmed vacuoles, Dermatomyositis with perifascicular atrophy, Polymyositis with CD8+ T cell endomysial invasion, and Immune-Mediated Necrotizing Myopathy with necrosis lacking significant inflammation.

Each idiopathic inflammatory myopathy possesses distinct clinical and histopathologic features. Dermatomyositis is characterized by humoral-mediated perivascular inflammation resulting in perifascicular atrophy. Polymyositis involves direct T-cell cytotoxicity against muscle fibers, appearing as endomysial CD8+ cells. Inclusion body myositis uniquely presents in older males with asymmetric distal weakness and shows rimmed vacuoles. Immune-mediated necrotizing myopathy features profound myonecrosis with scant inflammation.

Adım Adım Çözüm

Analyze the demographic and clinical features of each patient to identify the specific inflammatory myopathy.

Diagnoses established: left_1 is Inclusion Body Myositis (IBM), left_2 is Dermatomyositis (DM), left_3 is Polymyositis (PM), left_4 is Immune-Mediated Necrotizing Myopathy (IMNM).

Age, symmetry, distal vs. proximal involvement, and the presence or absence of skin findings/autoantibodies reliably differentiate the idiopathic inflammatory myopathies clinically.

Correlate each identified myopathy with its primary underlying immunopathologic mechanism.

DM is a humoral microangiopathy (perimysial), PM/IBM are cytotoxic T-cell processes (endomysial), and IMNM is an antibody-mediated necrotizing process.

Understanding the pathophysiology is essential to predicting the histologic appearance on biopsy.

Select the histologic description that matches the pathophysiology of the condition.

IBM matches rimmed vacuoles; DM matches perifascicular atrophy; PM matches CD8+ endomysial invasion; IMNM matches necrosis without inflammation.

Muscle biopsy remains the definitive gold standard for confirming specific subtypes of inflammatory myopathies.

Anahtar Kavram

Clinicopathologic correlation of idiopathic inflammatory myopathies

Tahmini Süre:2m 0s

Soru 1260Soru →

A 42-year-old man is brought to the emergency department by paramedics after his roommate found him unarousable. The roommate reports that the patient has a long-standing history of alcohol use disorder and has been binge drinking for the past two weeks with minimal food intake. Vital signs include a blood pressure of $105/65$ mm Hg, heart rate of $112$ /min, and respiratory rate of $24$ /min. On physical examination, the patient is somnolent but withdraws to painful stimuli. The mucous membranes are parched. There is no asterixis or jaundice. Laboratory studies are obtained and reveal the following:

Laboratory Test	Result
Sodium	$136$ mEq/L
Potassium	$3.8$ mEq/L
Chloride	$98$ mEq/L
Bicarbonate	$12$ mEq/L
Blood urea nitrogen	$45$ mg/dL
Creatinine	$1.5$ mg/dL
Glucose	$75$ mg/dL

Arterial blood gas analysis on room air shows:

Test	Result
pH	$7.26$
$PaCO_2$	$34$ mm Hg
$PaO_2$	$92$ mm Hg

Which of the following best characterizes this patient's acid-base status?

High anion gap metabolic acidosis with appropriate respiratory compensation

High anion gap metabolic acidosis and concurrent respiratory acidosis

High anion gap metabolic acidosis and concurrent respiratory alkalosis

Normal anion gap metabolic acidosis with appropriate respiratory compensation

Normal anion gap metabolic acidosis and concurrent respiratory acidosis

Cevabı ve açıklamayı göster

Cevap: High anion gap metabolic acidosis and concurrent respiratory acidosis

Cevap

High anion gap metabolic acidosis and concurrent respiratory acidosis

The patient's presentation and laboratory findings denote a mixed acid-base disorder. The initial step in interpretation is looking at the pH and bicarbonate; a pH of

7.26

with a bicarbonate of

12

mEq/L indicates a primary metabolic acidosis. Next, calculating the anion gap (

Na^+ - [Cl^- + HCO_3^-]

) yields

136 - (98 + 12) = 26

mEq/L. An anion gap

> 12

mEq/L defines a high anion gap metabolic acidosis (likely alcoholic ketoacidosis in this starved, binge-drinking patient). Finally, one must determine if the respiratory compensation is appropriate using Winter's formula (

Expected\ PaCO_2 = 1.5 \times [HCO_3^-] + 8 \pm 2

). For this patient, the expected

PaCO_2

1.5 \times 12 + 8 = 26 \pm 2

mm Hg. The patient's measured

PaCO_2

34

mm Hg. Because the measured

PaCO_2

is higher than the expected compensatory range (

24-28

mm Hg), the patient has inadequate alveolar ventilation, resulting in a concurrent respiratory acidosis. This hypoventilation is likely secondary to central nervous system depression from severe alcohol intoxication.

Adım Adım Çözüm

Determine the primary acid-base disturbance by evaluating the pH and serum bicarbonate.

The pH is

7.26

(acidemia) and the

HCO_3^-

12

mEq/L (low), which indicates a primary metabolic acidosis.

Identifying the primary disturbance is the necessary first step to guide further calculations.

Calculate the serum anion gap using the formula:

Na^+ - (Cl^- + HCO_3^-)

The anion gap is

136 - (98 + 12) = 26

mEq/L. Since this is greater than

12

mEq/L, it is a high anion gap metabolic acidosis.

The anion gap differentiates between causes of metabolic acidosis (e.g., ketoacidosis vs. renal tubular acidosis).

Calculate the expected respiratory compensation using Winter's formula:

Expected\ PaCO_2 = (1.5 \times HCO_3^-) + 8 \pm 2

The expected

PaCO_2 = (1.5 \times 12) + 8 \pm 2 = 26 \pm 2

mm Hg (range

24-28

mm Hg).

Winter's formula determines if the lungs are adequately compensating for the metabolic acidosis.

Compare the measured

PaCO_2

to the expected

PaCO_2

to identify any secondary concurrent disorders.

The measured

PaCO_2

34

mm Hg, which is higher than the expected maximum of

28

mm Hg. This indicates a concurrent respiratory acidosis.

An inappropriately elevated

PaCO_2

in the setting of a metabolic acidosis means the patient is hypoventilating relative to their metabolic demand.

Anahtar Kavram

Evaluation of a metabolic acidosis requires calculating the anion gap to determine the etiology and applying Winter's formula to identify any concurrent respiratory acid-base disturbances.

ÖncekiSayfa 63 / 158Sonraki

Internal Medicine

Cevap

Adım Adım Çözüm

Anahtar Kavram

Sık Yapılan Hatalar

Cevap

Adım Adım Çözüm

Anahtar Kavram

Sık Yapılan Hatalar

Cevap

Adım Adım Çözüm

Anahtar Kavram

Sık Yapılan Hatalar

Cevap

Adım Adım Çözüm

Anahtar Kavram

Sık Yapılan Hatalar

Cevap

Adım Adım Çözüm

Anahtar Kavram

Sık Yapılan Hatalar

Cevap

Adım Adım Çözüm

Anahtar Kavram

Sık Yapılan Hatalar

Cevap

Adım Adım Çözüm

Anahtar Kavram

Sık Yapılan Hatalar

Cevap

Adım Adım Çözüm

Anahtar Kavram

Sık Yapılan Hatalar

Cevap

Adım Adım Çözüm

Anahtar Kavram

Sık Yapılan Hatalar

Cevap

Adım Adım Çözüm

Anahtar Kavram

Sık Yapılan Hatalar

Cevap

Adım Adım Çözüm

Anahtar Kavram

Sık Yapılan Hatalar

Cevap

Adım Adım Çözüm

Anahtar Kavram

Sık Yapılan Hatalar

Cevap

Adım Adım Çözüm

Anahtar Kavram

Sık Yapılan Hatalar

Cevap

Adım Adım Çözüm

Anahtar Kavram

Sık Yapılan Hatalar

Cevap

Adım Adım Çözüm

Anahtar Kavram

Sık Yapılan Hatalar

Alternatif Yöntem

Cevap

Adım Adım Çözüm

Anahtar Kavram

Sık Yapılan Hatalar

Cevap

Adım Adım Çözüm

Anahtar Kavram

Sık Yapılan Hatalar

Cevap

Adım Adım Çözüm

Anahtar Kavram

Sık Yapılan Hatalar

Cevap

Adım Adım Çözüm

Anahtar Kavram

Sık Yapılan Hatalar

Cevap

Adım Adım Çözüm